Bank Of America Corp Vista Gen Therapeutics, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.3 $5,098 - $12,746	-42,488 Reduced 34.06%	82,259 $9,000
Q4 2022 Feb 10, 2023	SELL	$0.09 - $0.16 $28,585 - $50,818	-317,617 Reduced 71.8%	124,747 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $60,831 - $464,923	434,508 Added 5530.91%	442,364 $67,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $129,554 - $254,692	-147,221 Reduced 94.93%	7,856 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $433,492 - $794,737	-380,257 Reduced 71.03%	155,077 $192,000

Q4 2021 Feb 08, 2022	BUY	$1.67 - $2.76 $892,611 - $1.48 Million	534,498 Added 63935.17%	535,334 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $3,877 - $5,106	-1,480 Reduced 63.9%	836 $2,000
Q2 2021 Sep 13, 2021	BUY	$1.96 - $3.15 $4,539 - $7,295	2,316 New	2,316 $7,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.